Transarterial Chemoembolization Combined With Apatinib for Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis

Transarterial Chemoembolization Combined With Apatinib for Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis

Background: Apatinib is a powerful inhibitor of vascular endothelial growth factor receptor-2. This study was aimed to investigate whether apatinib could improve the efficacy of transarterial chemoembolization (TACE) in patients with advanced hepatocellular carcinoma (HCC).Methods: Between June 2015...

Full description

Bibliographic Details
Main Authors: Xuefeng Kan, Bin Liang, Guofeng Zhou, Bin Xiong, Feng Pan, Yanqiao Ren, Yanyan Cao, Jihua Wang, Fan Yang, Chuansheng Zheng
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-07-01
Series:Frontiers in Oncology
Subjects:
apatinib
transarterial chemoembolization
hepatocellular carcinoma
propensity score matching
adverse effects
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.00970/full

Similar Items

Similar Items